IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 83 filers reported holding IGM BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,843,716 | -9.5% | 2,136,972 | +0.1% | 0.00% | 0.0% |
| Q2 2023 | $19,707,148 | -15.2% | 2,135,119 | +26.3% | 0.00% | +100.0% |
| Q1 2023 | $23,236,840 | +97.7% | 1,691,182 | +144.8% | 0.00% | 0.0% |
| Q4 2022 | $11,753,196 | +97843.3% | 690,958 | +130515.9% | 0.00% | – |
| Q3 2022 | $12,000 | +140.0% | 529 | +72.3% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 307 | +19.9% | 0.00% | – |
| Q1 2022 | $7,000 | -99.9% | 256 | -99.7% | 0.00% | – |
| Q3 2021 | $5,877,000 | -28.9% | 89,368 | -10.1% | 0.00% | -100.0% |
| Q2 2021 | $8,267,000 | -11.7% | 99,368 | -18.6% | 0.00% | 0.0% |
| Q1 2021 | $9,361,000 | -37.9% | 122,068 | -28.6% | 0.00% | 0.0% |
| Q4 2020 | $15,086,000 | -5.9% | 170,868 | -21.3% | 0.00% | -50.0% |
| Q3 2020 | $16,026,000 | +1066.4% | 217,128 | +1053.9% | 0.00% | – |
| Q2 2020 | $1,374,000 | +89.3% | 18,817 | +45.6% | 0.00% | – |
| Q1 2020 | $726,000 | +47.3% | 12,928 | 0.0% | 0.00% | – |
| Q4 2019 | $493,000 | – | 12,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |